{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:33:17Z","timestamp":1791369197007,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V102C-202"],"award-info":[{"award-number":["V102C-202"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009096","name":"Taiwan Clinical Oncology Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009096","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chong Hin Loon Memorial Cancer and Biotherapy Research Center, National Yang-Ming University"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jmii.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T03:10:15Z","timestamp":1422587415000},"page":"567-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"49","author":[{"given":"Yao-Chung","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hsuan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Wen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hung","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-930X","authenticated-orcid":false,"given":"Jyh-Pyng","family":"Gau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Tsai","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hwang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzeon-Jye","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hwai","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2015.01.002_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkt389","article-title":"Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects","volume":"68","author":"Akan","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2015.01.002_bib2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.01.002_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1704662","article-title":"Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis","volume":"34","author":"Jantunen","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib4","first-page":"175","article-title":"Epidemiology and treatment approaches in management of invasive fungal infections","volume":"3","author":"Kriengkauykiat","year":"2011","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jmii.2015.01.002_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.2002.03259.x","article-title":"Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients","volume":"116","author":"Martino","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmii.2015.01.002_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clinthera.2013.11.010","article-title":"Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis","volume":"36","author":"Ziakas","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.jmii.2015.01.002_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","article-title":"Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation","volume":"47","author":"Garcia-Vidal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.01.002_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","article-title":"Risk stratification for invasive aspergillosis in immunocompromised patients","volume":"1272","author":"Herbrecht","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jmii.2015.01.002_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.01.002_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11046-009-9196-6","article-title":"Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint","volume":"168","author":"Bow","year":"2009","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jmii.2015.01.002_bib11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbmt.2013.05.018","article-title":"Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience","volume":"19","author":"Omer","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib12","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/bmt.2010.38","article-title":"Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT","volume":"45","author":"Blennow","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2141.2007.06812.x","article-title":"Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients","volume":"139","author":"Barnes","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmii.2015.01.002_bib14","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1086\/652761","article-title":"Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation","volume":"50","author":"Panackal","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.01.002_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJM197504242921706","article-title":"Bone-marrow transplantation","volume":"292","author":"Thomas","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2015.01.002_bib16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib18","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.01.002_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2013.136","article-title":"Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients","volume":"49","author":"Hol","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.bmt.1700737","article-title":"Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients","volume":"19","author":"Jantunen","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/bbmt.2002.v8.pm12374456","article-title":"Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study","volume":"8","author":"Junghanss","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bmt.2009.39","article-title":"Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients","volume":"44","author":"Mikulska","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/jac\/dkn027","article-title":"Risk factors for breakthrough invasive fungal infection during secondary prophylaxis","volume":"61","author":"Cornely","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2015.01.002_bib24","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.bbmt.2012.11.055","article-title":"Outcomes of allogeneic HSCT for patients with hematologic malignancies (AML, ALL, MDS, CML) with and without pre-existing fungal infections: A CIBMTR study","volume":"19","author":"Maziarz","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/516480","article-title":"Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation","volume":"175","author":"Wald","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2015.01.002_bib26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/cid\/cit391","volume":"57","author":"Styczynski","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.01.002_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/bmt.2008.373","article-title":"Prophylaxis regimens for GVHD: systematic review and meta-analysis","volume":"43","author":"Ram","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.01.002_bib28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2015.01.002_bib29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/1469-0691.12120","article-title":"Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation","volume":"19","author":"Sun","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2015.01.002_bib30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1469-0691.2011.03697.x","article-title":"The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in\u00a0vitro T-cell depletion","volume":"18","author":"Sun","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2015.01.002_bib31","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cncr.22909","article-title":"Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation","volume":"110","author":"Kontoyiannis","year":"2007","journal-title":"Cancer"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:20:43Z","timestamp":1761657643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118215000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1684118215000262"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2015.01.002","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC","name":"copyright","label":"Copyright"}]}}